Compliance Rate

Compliance Rate 0%
Compliant submissions 0
Incompliant submissions 0
Total trials 0

My Organizations' Clinical Trials

Showing 5 of 5 entries
View as:

Safety and Dose Ranging Study of Human Insulin Receptor MAb-IDUA Fusion Protein in Adults and Children With MPS I

Phase: N/A Priority: Normal
NCT ID: NCT03053089 Org: User:
Start: 10/31/15 End: 02/01/18 Due: 02/01/19

Safety and Dose Ranging Study of Insulin Receptor MAb-IDUA Fusion Protein in Patients With MPS I

Phase: N/A Priority: Normal
NCT ID: NCT02371226 Org: User:
Start: 07/31/15 End: 02/01/17 Due: 02/01/18

Safety and Dose Ranging Study of Insulin Receptor MoAb-IDS Fusion Protein in Patients With Hunter Syndrome

Phase: N/A Priority: Normal
NCT ID: NCT02262338 Org: User:
Start: 04/30/15 End: 03/27/17 Due: 03/27/18

Extension Study Evaluating Long Term Safety and Activity of AGT-181 in Children With MPS I

Phase: N/A Priority: Normal
NCT ID: NCT03071341 Org: User:
Start: 10/31/16 End: 02/01/18 Due: 02/01/19

Extension Study of AGT-181-102 to Evaluate Long Term Safety and Activity of AGT-181

Phase: N/A Priority: Normal
NCT ID: NCT02597114 Org: User:
Start: 11/30/15 End: 08/02/18 Due: 08/02/19